Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), Atai Beckley NV (NASDAQ:ATAI), Rapport Therapeutics Inc (NASDAQ:RAPP) and Phathom Pharmaceuticals Inc (NASDAQ:PHAT).
Xeris Biopharma Holdings has a consensus price target of $8.85.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $7.1 last updated December 16, 2025 at 4:00 PM EST.
There are no upcoming dividends for Xeris Biopharma Holdings.
Xeris Biopharma Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.